CNBDA
CNBDA is a selective SHP2 inhibitor with an IC50 of 5 μM. CNBDA binds to the active site of SHP2 through interactions with surrounding positively charged and polar amino acids, inhibits the PTPase activity of SHP2, and blocks the autodephosphorylation of SHP2. CNBDA inhibits the transformed phenotype, proliferation, anchorage-independent growth, and mammosphere formation of breast cancer cells, as well as EGF-induced Ras-ERK and PI3K-Akt signaling pathways, downregulates HER2 expression, and induces cell death. CNBDA can be used in breast cancer-related research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2101321-90-6
- Formule: C30H40O7
- Masse moléculaire:512.64
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform EGFR
More
Activité biologique
Description
IC50 & Target
[1]|
HER2 |
ERK2 |
Akt |
In Vitro
CNBDA (61 nM - 4 mM; 10 min) potently inhibits the PTPase activity of purified SHP2 with an IC50 of 5 μM, showing 25-fold greater selectivity over the homologous SHP1 enzyme[1].
CNBDA (200 nM; overnight serum starvation, followed by 10 min EGF stimulation) inhibits the PTPase activity of endogenous SHP2 in BT474 and JIMT-1 HER2-positive breast cancer cells, as evidenced by accumulation of phosphorylated Tyr542-SHP2 following EGF stimulation[1].
CNBDA (0.25-1 μM; 24-72 h) suppresses proliferation and induces cell death in BT474 and JIMT-1 HER2-positive breast cancer cells with IC50 values of 300 nM and 400 nM, respectively, while nontransformed MCF-10A breast epithelial cells show high resistance to the compound[1].
CNBDA (0.25-1 μM; 10 days) suppresses anchorage-independent growth of BT474 and JIMT-1 HER2-positive breast cancer cells in a concentration-dependent manner, eliminating colony formation at 1 μM[1].
CNBDA (200 nM; overnight serum starvation, followed by 10 min to 4 h EGF stimulation) suppresses sustained EGF-induced activation of the Akt and ERK1/2 signaling pathways and downregulates HER2 expression in BT474 and JIMT-1 HER2-positive breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:BT474 HER2-positive breast cancer cells, JIMT-1 HER2-positive breast cancer cells, MCF-10A nontransformed breast epithelial cells
-
Concentration:0.25, 0.5, 1 μM
-
Incubation Time:24, 48, 72 h
-
Result:Suppressed proliferation in BT474 cells at 0.25 μM, and induced cell death at 0.5 μM and above.
Reduced BT474 cell viability with an IC50 of 300 nM.
Suppressed proliferation in JIMT-1 cells at 0.25 μM, and induced cell death at 0.5 μM and above.
Reduced JIMT-1 cell viability with an IC50 of 400 nM.
Reduced MCF-10A cell viability by only 20% at 1.6 μM.
Chemical Information
-
CAS No. 2101321-90-6
-
Masse moléculaire 512.64
-
Formule C30H40O7
-
SMILES
O=C(O)C=1C=CC(=CC1)C2=CC(=C(OCCCCCCCCC)C(=C2)CCCC(=O)O)CCCC(=O)O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)